SER-109
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SER-109, covering 2018-07-26 to 2023-04-27. Get the full timeline:
Most recent: Clinical Trial Update: ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection [Phase 3]